Levine Leichtman Capital Partners Invests in HCD Economics
Founded in 2013, HCD Economics is an academically backed organization operating in the high-growth health economics and outcomes research (HEOR) and real-world evidence (RWE) space. HCD Economics specializes in conducting burden of disease research and gathering of proprietary health economic evidence needed for market access, pricing, and reimbursement to support pharmaceutical clients across the U.S., U.K. and other key European markets.
Levine Leichtman Capital Partners
The Premium Lower and Middle Market M&A Platform
For full transactional data, join PrivSource today!Apply →